Literature DB >> 31075402

Emergence of IMP-producing hypervirulent Klebsiella pneumoniae carrying a pLVPK-like virulence plasmid.

Sohei Harada1, Kotaro Aoki2, Yoshikazu Ishii2, Yuki Ohno3, Akihiro Nakamura4, Masaru Komatsu4, Kazuhiro Tateda2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31075402     DOI： 10.1016/j.ijantimicag.2019.05.007

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  11 in total

1.  Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.

Authors:  Sohei Harada; Kotaro Aoki; Shungo Yamamoto; Yoshikazu Ishii; Noritaka Sekiya; Hanako Kurai; Keiichi Furukawa; Asako Doi; Kentaro Tochitani; Kenji Kubo; Yukihiro Yamaguchi; Masashi Narita; Shinya Kamiyama; Jun Suzuki; Takahiko Fukuchi; Yoshiaki Gu; Keiji Okinaka; Soichi Shiiki; Kayoko Hayakawa; Natsuo Tachikawa; Kei Kasahara; Tadahiro Nakamura; Kyoko Yokota; Masanari Komatsu; Misaki Takamiya; Kazuhiro Tateda; Yohei Doi
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

2.  Emergence of Tigecycline Nonsusceptible and IMP-4 Carbapenemase-Producing K2-ST65 Hypervirulent Klebsiella pneumoniae in China.

Authors:  Yawei Zhang; Xiaojuan Wang; Qi Wang; Hongbin Chen; Henan Li; Shuyi Wang; Ruobing Wang; Hui Wang
Journal:  Microbiol Spectr       Date:  2021-10-27

Review 3.  The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae.

Authors:  Kimberly A Walker; Virginia L Miller
Journal:  Curr Opin Microbiol       Date:  2020-02-12       Impact factor: 7.934

4.  Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia.

Authors:  Kelly L Wyres; To N T Nguyen; Margaret M C Lam; Louise M Judd; Nguyen van Vinh Chau; David A B Dance; Margaret Ip; Abhilasha Karkey; Clare L Ling; Thyl Miliya; Paul N Newton; Nguyen Phu Huong Lan; Amphone Sengduangphachanh; Paul Turner; Balaji Veeraraghavan; Phat Voong Vinh; Manivanh Vongsouvath; Nicholas R Thomson; Stephen Baker; Kathryn E Holt
Journal:  Genome Med       Date:  2020-01-16       Impact factor: 11.117

5.  The Galleria mellonella Infection Model Does Not Accurately Differentiate between Hypervirulent and Classical Klebsiella pneumoniae.

Authors:  Thomas A Russo; Ulrike MacDonald
Journal:  mSphere       Date:  2020-01-08       Impact factor: 4.389

Review 6.  Epidemiological Characteristics and Formation Mechanisms of Multidrug-Resistant Hypervirulent Klebsiella pneumoniae.

Authors:  Miran Tang; Xin Kong; Jingchen Hao; Jinbo Liu
Journal:  Front Microbiol       Date:  2020-11-20       Impact factor: 5.640

7.  An Outbreak of ST859-K19 Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae in a Chinese Teaching Hospital.

Authors:  Junying Zhu; Xuemei Jiang; Lina Zhao; Min Li
Journal:  mSystems       Date:  2022-05-16       Impact factor: 7.324

8.  Genomic epidemiology and temperature dependency of hypermucoviscous Klebsiella pneumoniae in Japan.

Authors:  Mi Nguyen-Tra Le; Shizuo Kayama; Kelly L Wyres; Liansheng Yu; Junzo Hisatsune; Masato Suzuki; Koji Yahara; Tsuneko Terachi; Kana Sawa; Shin Takahashi; Toshihiko Okuhara; Kunihiko Kohama; Kathryn E Holt; Tetsu Mizutani; Hiroki Ohge; Motoyuki Sugai
Journal:  Microb Genom       Date:  2022-05

9.  Dynamic Epidemiology and Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae in Wenzhou, China from 2003 to 2016.

Authors:  Yajie Zhao; Siqin Zhang; Renchi Fang; Qing Wu; Jiahui Li; Yizhi Zhang; Andrea Rocker; Jianming Cao; Trevor Lithgow; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-03-31       Impact factor: 4.003

Review 10.  Neonatal Sepsis: The Impact of Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae.

Authors:  Subhankar Mukherjee; Shravani Mitra; Shanta Dutta; Sulagna Basu
Journal:  Front Med (Lausanne)       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.